PDS Biotechnology Management
Management criteria checks 3/4
PDS Biotechnology's CEO is Frank Bedu-Addo, appointed in Mar 2019, has a tenure of 5.08 years. total yearly compensation is $2.30M, comprised of 23.5% salary and 76.5% bonuses, including company stock and options. directly owns 1.88% of the company’s shares, worth €2.11M. The average tenure of the management team and the board of directors is 2.5 years and 5.1 years respectively.
Key information
Frank Bedu-Addo
Chief executive officer
US$2.3m
Total compensation
| CEO salary percentage | 23.5% |
| CEO tenure | 5.1yrs |
| CEO ownership | 1.9% |
| Management average tenure | 2.5yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$43m |
| Sep 30 2023 | n/a | n/a | -US$51m |
| Jun 30 2023 | n/a | n/a | -US$48m |
| Mar 31 2023 | n/a | n/a | -US$42m |
| Dec 31 2022 | US$2m | US$540k | -US$41m |
| Sep 30 2022 | n/a | n/a | -US$28m |
| Jun 30 2022 | n/a | n/a | -US$28m |
| Mar 31 2022 | n/a | n/a | -US$22m |
| Dec 31 2021 | US$7m | US$475k | -US$17m |
| Sep 30 2021 | n/a | n/a | -US$15m |
| Jun 30 2021 | n/a | n/a | -US$12m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | US$815k | US$450k | -US$15m |
| Sep 30 2020 | n/a | n/a | -US$15m |
| Jun 30 2020 | n/a | n/a | -US$17m |
| Mar 31 2020 | n/a | n/a | -US$18m |
| Dec 31 2019 | US$3m | US$356k | -US$7m |
Compensation vs Market: Frank's total compensation ($USD2.30M) is above average for companies of similar size in the German market ($USD401.52K).
Compensation vs Earnings: Frank's compensation has been consistent with company performance over the past year.
CEO
Frank Bedu-Addo (58 yo)
5.1yrs
Tenure
US$2,302,548
Compensation
Dr. Frank K. Bedu-Addo, Ph D., served as Interim Principal Financial Officer for PDS Biotechnology Corporation since September 30, 2021 until October 2021. He serves as Chief Executive Officer of PDS Biote...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.1yrs | US$2.30m | 1.88% $ 2.1m | |
| Principal Financial & Accounting Officer and CFO | less than a year | no data | no data | |
| VP of Research & Development | 3.3yrs | no data | no data | |
| Chief Scientific Officer | 5.1yrs | US$1.32m | 0.34% $ 376.9k | |
| Head of Investor Relations | no data | no data | no data | |
| Senior VP | 1.8yrs | no data | 0% $ 0 | |
| Chief Medical Officer | less than a year | no data | no data | |
| Controller | no data | no data | no data |
2.5yrs
Average Tenure
59yo
Average Age
Experienced Management: EU6's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.1yrs | US$2.30m | 1.88% $ 2.1m | |
| Independent Director | 5.1yrs | US$89.82k | 0.13% $ 140.8k | |
| Independent Director | 5.1yrs | US$78.82k | 1.21% $ 1.4m | |
| Independent Chairman | 5yrs | US$120.32k | 0.17% $ 194.6k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4.2yrs | US$90.82k | 0.032% $ 35.9k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chair of the Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
5.1yrs
Average Tenure
62yo
Average Age
Experienced Board: EU6's board of directors are considered experienced (5.1 years average tenure).